Tech Company M&A Transactions

Arranta Bio Acquisition

On 2/18/2022, Arranta Bio was acquired by Recipharm. The financial terms of the deal were not announced.

Transaction Overview

Company Name
Acquired By
Announced On
2/18/2022
Transaction Type
M&A
Amount
Unknown
M&A Terms
The Arranta Bio acquisition expand Recipharm's biologics offerings in the United States. Financial terms were not disclosed.

Company Information

Company Status
Acquired or Merged
Industry
Biopharmaceutical
Mailing Address
650 Pleasant St.
Watertown, MA 02472
USA
Phone
Undisclosed
Email Address
Overview
Arranta Bio is delivering on its vision to build the best-in-class microbiome contract development and manufacturing organization (CDMO) through the establishment of a facility dedicated to process development and cGMP clinical supply with a commercial-ready capability.
Profile
Arranta Bio LinkedIn Company Profile
Social Media
Arranta Bio Company Twitter Account
Company News
Arranta Bio News
Facebook
Arranta Bio on Facebook
YouTube
Arranta Bio on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Mark Bamforth
  Mark Bamforth LinkedIn Profile  Mark Bamforth Twitter Account  Mark Bamforth News  Mark Bamforth on Facebook
Founder
Iain Baird
  Iain Baird LinkedIn Profile  Iain Baird Twitter Account  Iain Baird News  Iain Baird on Facebook


 

 

Browse more venture capital transactions:

Prev: 2/18/2022: Alma SAS venture capital transaction
Next: 2/18/2022: Sekr venture capital transaction

 

Share this article

 


Where The Data Comes From

We do our best to report on every notable VC transaction. VC investment data records reported here come from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary